Sensus Healthcare, Inc. (SRTS)
SRTS Stock Price Chart
Explore Sensus Healthcare, Inc. interactive price chart. Choose custom timeframes to analyze SRTS price movements and trends.
SRTS Company Profile
Discover essential business fundamentals and corporate details for Sensus Healthcare, Inc. (SRTS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
26 Jul 2016
Employees
54.00
Website
https://www.sensushealthcare.comCEO
Joseph C. Sardano
Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
SRTS Financial Timeline
Browse a chronological timeline of Sensus Healthcare, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.07.
Earnings released on 7 Aug 2025
EPS came in at -$0.06 falling short of the estimated $0.01 by -700.00%, while revenue for the quarter reached $7.32M , beating expectations by +16.96%.
Earnings released on 15 May 2025
EPS came in at -$0.16 falling short of the estimated $0.04 by -500.00%, while revenue for the quarter reached $8.34M , beating expectations by +15.34%.
Earnings released on 5 Feb 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $13.07M , beating expectations by +105.61%.
Earnings released on 14 Nov 2024
EPS came in at $0.07 surpassing the estimated $0.01 by +799.74%, while revenue for the quarter reached $8.84M , beating expectations by +49.93%.
Earnings released on 8 Aug 2024
EPS came in at $0.10 surpassing the estimated $0.02 by +328.63%, while revenue for the quarter reached $9.24M , beating expectations by +31.99%.
Earnings released on 9 May 2024
EPS came in at $0.14 surpassing the estimated -$0.05 by +380.00%, while revenue for the quarter reached $10.66M , beating expectations by +158.81%.
Earnings released on 8 Feb 2024
EPS came in at $0.26 surpassing the estimated $0.12 by +116.67%, while revenue for the quarter reached $12.57M , beating expectations by +13.62%.
Earnings released on 9 Nov 2023
EPS came in at -$0.09 falling short of the estimated -$0.02 by -400.00%, while revenue for the quarter reached $3.90M , missing expectations by -33.94%.
Earnings released on 3 Aug 2023
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $4.53M , missing expectations by -0.51%.
Earnings released on 3 May 2023
EPS came in at -$0.12 falling short of the estimated $0.11 by -209.09%, while revenue for the quarter reached $3.41M , missing expectations by -66.30%.
Earnings released on 9 Feb 2023
EPS came in at $0.17 falling short of the estimated $0.23 by -26.09%, while revenue for the quarter reached $13.11M , beating expectations by +1.00%.
Earnings released on 3 Nov 2022
EPS came in at $0.11 falling short of the estimated $0.13 by -15.38%, while revenue for the quarter reached $9.01M , missing expectations by -5.54%.
Earnings released on 4 Aug 2022
EPS came in at $0.21 surpassing the estimated $0.13 by +61.54%, while revenue for the quarter reached $12.08M , beating expectations by +26.42%.
Earnings released on 5 May 2022
EPS came in at $0.20 surpassing the estimated $0.06 by +233.33%, while revenue for the quarter reached $10.34M , beating expectations by +53.55%.
Earnings released on 10 Feb 2022
EPS came in at $0.32 surpassing the estimated $0.16 by +100.00%, while revenue for the quarter reached $13.03M , beating expectations by +17.53%.
Earnings released on 4 Nov 2021
EPS came in at $0.01 surpassing the estimated $0.00 by +159.74%, while revenue for the quarter reached $5.53M , missing expectations by -0.81%.
Earnings released on 5 Aug 2021
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $5.42M , meeting expectations.
Earnings released on 6 May 2021
EPS came in at -$0.07 surpassing the estimated -$0.09 by +22.22%, while revenue for the quarter reached $3.07M , missing expectations by -23.08%.
Earnings released on 25 Feb 2021
EPS came in at $0.06 surpassing the estimated -$0.12 by +150.00%, while revenue for the quarter reached $5.09M , missing expectations by -56.35%.
Earnings released on 5 Nov 2020
EPS came in at -$0.10 surpassing the estimated -$0.13 by +23.08%, while revenue for the quarter reached $1.62M , missing expectations by -23.08%.
SRTS Stock Performance
Access detailed SRTS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.